Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s footer has been updated to indicate the ClinicalTrials.gov site revision was bumped from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded the Bologna location entries 'Province Of Bologna' and 'Bologna, Province Of Bologna, Italy, 15-40138' and removed the lowercase versions. Updated the revision tag to v3.5.2, replacing v3.5.0.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedHepatocellular carcinoma tag added and a new resource entry for the Genetic and Rare Diseases Information Center. Page revision updated to v3.5.0.SummaryDifference0.2%

- Check56 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded: Revision: v3.4.2. Removed: the funding-status notice and Revision: v3.4.1 banner. These changes do not affect the study details or the information presented on the page.SummaryDifference0.4%

- Check92 days agoChange DetectedNew site-wide notice about government funding and NIH operating status is displayed at the top of the page. The page header now shows a Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.